These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 383096)

  • 1. [Neuroleptic infusion therapy with high-dosed fluphenazine (author's transl)].
    Fünfgeld EW; Kulhanek F
    Arzneimittelforschung; 1978; 28(9):1489-91. PubMed ID: 383096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.
    Midha KK; Hubbard JW; Marder SR; Marshall BD; Van Putten T
    J Psychiatry Neurosci; 1994 Jul; 19(4):254-64. PubMed ID: 7918346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An open clinical trial with the long-acting neuroleptics flupenthixol decanoate and fluphenazine decanoate in the maintenance treatment of schizophrenia.
    Kong DS; Yeo SH
    Pharmatherapeutica; 1989; 5(6):371-9. PubMed ID: 2687894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fluphenazine dihydrochloride--a multicenter trial on 660 patients (author's transl)].
    Pieschl D; Kulhanek F; Piergies A
    Arzneimittelforschung; 1978; 28(9):1503-4. PubMed ID: 383100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative investigation of action and side effects in intravenous, intramuscular and oral application of fluphenazine dihydrochloride (author's transl)].
    Maurer YA
    Pharmakopsychiatr Neuropsychopharmakol; 1979 Sep; 12(5):366-74. PubMed ID: 504343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of parenteral administration of fluphenazine decanoate in the treatment of chronic schizophrenics.
    Kurland AA; Dim BH; Olsson JE
    Dis Nerv Syst; 1970 Sep; 31():Suppl:18-23. PubMed ID: 5476356
    [No Abstract]   [Full Text] [Related]  

  • 7. [The depot neuroleptic agent fluspirilene (author's transl)].
    Angst J; Frei M; Scharfetter Chr
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Jan; 6(1):13-28. PubMed ID: 4602371
    [No Abstract]   [Full Text] [Related]  

  • 8. Relapse in chronic schizophrenics treated with fluphenazine decanoate is associated with low serum neuroleptic levels.
    Jayaram G; Coyle J; Tune L
    J Clin Psychiatry; 1986 May; 47(5):247-8. PubMed ID: 3700342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
    Weiser G; Gattringer B; Bengesser G
    Wien Med Wochenschr; 1973 Apr; 123(14):227-30. PubMed ID: 4695598
    [No Abstract]   [Full Text] [Related]  

  • 10. The initiation of long-term pharmacotherapy in schizophrenia: dosage and side effect comparisons between oral and depot fluphenazine.
    Schooler NR; Levine J
    Pharmakopsychiatr Neuropsychopharmakol; 1976 Jul; 9(4):159-69. PubMed ID: 790413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penfluridol versus oral fluphenazine in the maintenance treatment of chronic schizophrenics.
    Charalampous KD; Thornby J; Ford BK; Freemesser GF
    Curr Ther Res Clin Exp; 1977 Feb; 21(2):215-23. PubMed ID: 403056
    [No Abstract]   [Full Text] [Related]  

  • 12. [Policlinical schizophrenia therapy with longtime neuroleptic agent fluphenazine decanoate].
    Haase HJ; Steuer A; Knaack M
    Med Welt; 1973 Feb; 24(8):306-7. PubMed ID: 4688219
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical observation on the effect of domestic fluphenazine decanoate in the treatment of schizophrenia---report of 431 cases (author's transl)].
    Zhang YF
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1981 Aug; 14(3):182-5. PubMed ID: 7333179
    [No Abstract]   [Full Text] [Related]  

  • 14. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 15. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
    Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
    Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
    [No Abstract]   [Full Text] [Related]  

  • 16. [Social integration of long-term paraphrenic patients with low-dose depot neuroleptic medication].
    Lesch OM; Dietzel-Rogan M; Musalek M; Rajna P; Rustembegovich A; Schjerve M; Walter H
    Psychiatr Prax; 1985 Mar; 12(2):63-8. PubMed ID: 3887443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution to the infusion therapy with fluphenazine in schizophrenics with regard to the control of the neuroleptic threshold].
    Dengler K
    Med Welt; 1969 Apr; 16():977-81. PubMed ID: 5784368
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical observations on the use of a long-acting phenothiazine (fluphenazine enanthate) in chronic schizophrenics.
    Christodoulidis H
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):311-5. PubMed ID: 4208347
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacogenic depressive syndromes in the course of schizophrenic psychoses (author's transl)].
    Müller P; Kind J; Steuber H
    Arzneimittelforschung; 1978; 28(9):1501-2. PubMed ID: 383099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A long term comparative trial of penfluridol and fluphenazine decanoate in schizophrenic outpatients.
    Iqbal MJ; Young MA; Charles J; Elgart B; Von Greiff H; Simpson GM
    J Clin Psychiatry; 1978 Apr; 39(4):375-9. PubMed ID: 580285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.